Cocrystal Pharma, Inc. (COCP)
1.12
-0.01
(-0.88%)
USD |
NASDAQ |
May 29, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Cocrystal Pharma Shareholders Equity (Quarterly) : 4.116M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CNBX Pharmaceuticals, Inc. | -2.534M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 386.80M |
| Fulcrum Therapeutics, Inc. | 333.30M |
| Definium Therapeutics, Inc. | 278.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.426M |
| Total Liabilities (Quarterly) | 3.31M |
| Debt to Equity Ratio | 0.346 |
| Current Ratio | 2.664 |
| Net Debt Paydown Yield | 0.55% |